Literature DB >> 18395333

Dietary agents for chemoprevention of prostate cancer.

Deeba N Syed1, Yewseok Suh, Farrukh Afaq, Hasan Mukhtar.   

Abstract

Prostate cancer (CaP) is the leading cause of cancer-related deaths in American men, responsible for over 29,000 deaths in the year 2007. Chemoprevention is a plausible and cost-effective approach to reduce cancer morbidity and mortality through inhibition of precancerous events before the occurrence of clinical disease. Indeed, CaP is an ideal candidate disease for chemopreventive intervention as it is typically diagnosed in the elderly population with a relatively slower rate of growth and progression. The potential of dietary substances to act as chemopreventive agents against CaP is increasingly appreciated. Further, epidemiological studies have identified significant correlations between CaP incidence and dietary habits. It is hoped that, combining the knowledge based on agents with targets, we will be able to build an armamentarium of naturally occurring chemopreventive substances that could prevent or slow down the development and progression of CaP. In this review, we have summarized the findings from clinical and preclinical studies on dietary agents including green tea, pomegranate, lupeol, fisetin, and delphinidin that are currently being investigated in our laboratory for their chemopreventive potential against CaP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395333      PMCID: PMC3220618          DOI: 10.1016/j.canlet.2008.02.050

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  41 in total

1.  A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.

Authors:  Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

2.  A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach.

Authors:  E Choan; Roanne Segal; Derek Jonker; Shawn Malone; Neil Reaume; Libni Eapen; Victor Gallant
Journal:  Urol Oncol       Date:  2005 Mar-Apr       Impact factor: 3.498

3.  Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer.

Authors:  Arshi Malik; Farrukh Afaq; Sami Sarfaraz; Vaqar M Adhami; Deeba N Syed; Hasan Mukhtar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-28       Impact factor: 11.205

4.  Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Authors:  Saverio Bettuzzi; Maurizio Brausi; Federica Rizzi; Giovanni Castagnetti; Giancarlo Peracchia; Arnaldo Corti
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

5.  Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions.

Authors:  Ephraim P Lansky; Wenguo Jiang; Huanbiao Mo; Lou Bravo; Paul Froom; Weiping Yu; Neil M Harris; Ishak Neeman; Moray J Campbell
Journal:  Invest New Drugs       Date:  2005-01       Impact factor: 3.850

6.  Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.

Authors:  Vaqar Mustafa Adhami; Arshi Malik; Najia Zaman; Sami Sarfaraz; Imtiaz Ahmad Siddiqui; Deeba Nadeem Syed; Farrukh Afaq; Farrukh Sierre Pasha; Mohammad Saleem; Hasan Mukhtar
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

7.  Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.

Authors:  I A Siddiqui; A Malik; V M Adhami; M Asim; B B Hafeez; S Sarfaraz; H Mukhtar
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

8.  The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.

Authors:  Andrea Caporali; Pierpaola Davalli; Serenella Astancolle; Domenico D'Arca; Maurizio Brausi; Saverio Bettuzzi; Arnaldo Corti
Journal:  Carcinogenesis       Date:  2004-09-09       Impact factor: 4.944

9.  Protective effects of lupeol and mango extract against androgen induced oxidative stress in Swiss albino mice.

Authors:  Sahdeo Prasad; Neetu Kalra; Madhulika Singh; Yogeshwer Shukla
Journal:  Asian J Androl       Date:  2007-12-20       Impact factor: 3.285

Review 10.  Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.

Authors:  Jennifer R Carlson; Brent A Bauer; Ann Vincent; Paul J Limburg; Ted Wilson
Journal:  Mayo Clin Proc       Date:  2007-06       Impact factor: 7.616

View more
  42 in total

Review 1.  Diet and prostate cancer: mechanisms of action and implications for chemoprevention.

Authors:  Vasundara Venkateswaran; Laurence H Klotz
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

2.  Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes.

Authors:  Uddhav P Kelavkar; Justin Hutzley; Kevin McHugh; Kenneth G D Allen; Anil Parwani
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

3.  Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis.

Authors:  Lei Wang; Wenfang Li; Muqing Lin; Monika Garcia; David Mulholland; Michael Lilly; Manuela Martins-Green
Journal:  Carcinogenesis       Date:  2014-07-14       Impact factor: 4.944

Review 4.  Nutraceuticals and prostate cancer prevention: a current review.

Authors:  Greg Trottier; Peter J Boström; Nathan Lawrentschuk; Neil E Fleshner
Journal:  Nat Rev Urol       Date:  2009-12-08       Impact factor: 14.432

5.  Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.

Authors:  Seung Joon Kim; Ernest Amankwah; Shahnjayla Connors; Hyun Y Park; Maria Rincon; Heather Cornnell; Ganna Chornokur; Arig Ibrahim Hashim; Junsung Choi; Ya-Yu Tsai; Robert W Engelman; Nagi Kumar; Jong Y Park
Journal:  Cancer Prev Res (Phila)       Date:  2014-02-05

6.  Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis.

Authors:  Lei Wang; Jeffrey Ho; Carlotta Glackin; Manuela Martins-Green
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

7.  Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells.

Authors:  Ewelina Szliszka; Zenon P Czuba; Bogdan Mazur; Lukasz Sedek; Andrzej Paradysz; Wojciech Krol
Journal:  Int J Mol Sci       Date:  2009-12-24       Impact factor: 5.923

8.  (2E)-2-Benzyl-idene-5,6-dimethoxy-indan-1-one.

Authors:  Mohamed Ashraf Ali; Rusli Ismail; Soo Choon Tan; Chin Sing Yeap; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-11

Review 9.  Diet, microRNAs and prostate cancer.

Authors:  Sharanjot Saini; Shahana Majid; Rajvir Dahiya
Journal:  Pharm Res       Date:  2010-03-11       Impact factor: 4.200

10.  Combinatorial cytotoxic effects of Curcuma longa and Zingiber officinale on the PC-3M prostate cancer cell line.

Authors:  Kesava Rao V Kurapati; Thangavel Samikkannu; Dakshayani B Kadiyala; Saiyed M Zainulabedin; Nimisha Gandhi; Sadhana S Sathaye; Manohar A Indap; Nawal Boukli; Jose W Rodriguez; Madhavan P N Nair
Journal:  J Basic Clin Physiol Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.